Vaccine therapy
ICBs
CERVICAL CANCER
Therapeutic vaccines used as a care option for cervical cancer patients in clinical trials can date back to 1995 according to our study. During the development of nearly 30 years, patterns of vaccine therapies have changed a lot. Currently, there are four vaccine types in the treatment of cervical cancer, including live vector, protein/peptide, nucleic acid, and cell-based vaccines (Since the effects of single vaccine therapies are usually kind of weak in the treatment of cervical cancer, most clinical trials of vaccine therapies started in recent years are combined with other multiple therapies. And research on the combination of vaccine therapies and ICBs is becoming popular.VB10.16 plus Atezolizumab. As a DNA vaccine, VB10.16 can deliver the encoded E6 and E7 antigens of HPV16 directedly to the professional antigen-presenting cells and trigger stronger immune responses (